Automating HSC gene engineering in a functionally closed system

Lucie Stamm received her doctoral degree in Biology from the University of Cologne, Germany, in 2018. After her studies, she joined Miltenyi Biotec and currently is the Global Product Manager for the hematopoietic stem cell portfolio. Closely working together with R&D, Lucie focuses on advancing tools for the manufacturing of gene-engineered HSCs.

Katharina Krämer received her master’s degree in Medical Biology from Radboud University Nijmegen, Netherlands, in 2011. After her studies, she gained extensive experience as a Global Product Manager in the field of personalized healthcare. Katharina joined Miltenyi Biotec in 2016, taking care of the CliniMACS CD34 Product Line.

Eleni Papanikolaou received her PhD from the Aristotle University of Thessaloniki in Greece and later proceeded with her postdoctoral research at the Department of Medical Genetics of the University of Washington, Seattle, enrolled in the Program of Excellence in Gene Therapy (PEGT) under the supervision of Professor George Stamatoyannopoulos, founder of the American Society of Gene and Cell Therapy (ASGCT). In 2013 she was appointed as Lecturer of Gene Therapy at the Medical School of National & Kapodistrian University of Athens, Greece and in May 2018 joined R&D at Miltenyi Biotec as a Manager of Hemopoietic Stem Cell Gene Therapy and Graft Engineering.